CCL2 and metabolic dysfunction-associated steatotic liver disease: Recent studies by Queck et al. suggested that systemic MCP-1 levels are mainly derived from macrophages within the liver and that chronic hepatic lipid accumulation, i.e., as present in non-alcoholic fatty liver disease, is associated with higher plasma MCP-1 levels [30].